Isotretinoin Actavis (Isotretinoin)

Isotretinoin binds to nuclear retinoic acid receptors, altering gene transcription that leads to smaller sebaceous glands, reduced sebum output, normalized follicular keratinization, and anti‑inflammatory effects. These actions collectively address the primary pathogenic factors of severe acne.

The dosing regimen for Isotretinoin Actavis is individualized by the prescribing clinician based on the patient’s body weight, severity of acne, and tolerance. The prescriber determines the appropriate daily dose and treatment duration, which typically ranges from several weeks to months.

Isotretinoin is classified as pregnancy category X and is contraindicated in pregnant women because of its high teratogenic potential. Women of child‑bearing potential must use effective contraception during treatment and for at least one month after discontinuation. Use while breastfeeding is also not recommended.

To order Isotretinoin Actavis, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and assistance with import documentation.

Compared with oral antibiotics or other systemic retinoids, isotretinoin offers a disease‑modifying effect that can produce long‑lasting remission after a finite course. Antibiotics manage inflammation but do not address sebum production, while other retinoids may have similar teratogenic risks but differ in potency and side‑effect profiles.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children. No refrigeration is required for this oral formulation.

Isotretinoin Actavis is taken orally, usually with a full glass of water. It can be taken with or without food, but a consistent approach (with meals or on an empty stomach) helps maintain stable absorption. Patients should follow the prescriber’s instructions regarding timing and any dietary considerations.

The most serious risks include teratogenicity (birth defects), severe depression or suicidal thoughts, hepatotoxicity with elevated liver enzymes, significant hypertriglyceridemia, and pseudotumor cerebri (increased intracranial pressure). Patients should be monitored closely for these events throughout therapy.

Isotretinoin should not be used by pregnant women, individuals planning pregnancy without reliable contraception, patients with known hypersensitivity to isotretinoin or any component of the formulation, those with active liver disease, uncontrolled hyperlipidemia, or severe psychiatric conditions without appropriate supervision.